Imbria Pharmaceuticals has a total of 96 patents globally, out of which 14 have been granted. Of these 96 patents, more than 71% patents are active. The United States of America is where Imbria Pharmaceuticals has filed the maximum number of patents, followed by Europe and Israel. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Imbria Pharmaceuticals.
Imbria Pharmaceuticals was founded in 2018. Imbria Pharmaceuticals is a clinical stage, privately held company creating innovative treatments for individuals with serious cardiometabolic illnesses. The clinical stage pipeline of the company is focused on repairing or increasing the cell’s ability to create energy in cardiovascular illnesses where energetic impairment is a significant contributor to symptoms and functional deficiencies.
Do read about some of the most popular patents of Imbria Pharmaceuticals which have been covered by us in this article and also you can find Imbria Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Imbria Pharmaceuticals patent portfolio.
How many patents does Imbria Pharmaceuticals have?
Imbria Pharmaceuticals has a total of 96 patents globally. These patents belong to 20 unique patent families. Out of 96 patents, 69 patents are active.
How Many Patents did Imbria Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Imbria Pharmaceuticals Applications Filed | Imbria Pharmaceuticals Patents Granted |
| 2023 | 1 | 4 |
| 2022 | 9 | 6 |
| 2021 | 32 | 2 |
| 2020 | 13 | 2 |
| 2019 | 20 | – |
| 2018 | 19 | – |
| 2017 | 2 | – |
How many Imbria Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Imbria Pharmaceuticals File in Different Countries?
Countries in which Imbria Pharmaceuticals Filed Patents
| Country | Patents |
| United States Of America | 29 |
| Europe | 12 |
| Israel | 8 |
| Australia | 7 |
| Korea (South) | 7 |
| China | 7 |
| Canada | 7 |
| Poland | 1 |
| Italy | 1 |
| Austria | 1 |
| Spain | 1 |
Where are Research Centers of Imbria Pharmaceuticals Patents Located?
10 Best Imbria Pharmaceuticals Patents
US10556013B2 is the most popular patent in the Imbria Pharmaceuticals portfolio and it has received 14 citations.
Below is the list of 10 most cited patents of Imbria Pharmaceuticals:
| Publication Number | Citation Count |
| US10556013B2 | 14 |
| US20190216936A1 | 8 |
| WO2020081361A1 | 8 |
| US10918728B2 | 4 |
| US20210353617A1 | 4 |
| WO2020243119A1 | 4 |
| US11376330B2 | 2 |
| US10953102B2 | 2 |
| WO2020247213A1 | 2 |
| US20220249463A1 | 1 |
What Percentage of Imbria Pharmaceuticals US Patent Applications Were Granted?
Imbria Pharmaceuticals (Excluding its subsidiaries) has filed 29 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 85.71%.
Below are the key stats of Imbria Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Imbria Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Brown Rudnick Llp | 29 | 85.71% |
What are Imbria Pharmaceuticals key innovation segments?
What Technologies are Covered by Imbria Pharmaceuticals?
The chart below distributes patents filed by Imbria Pharmaceuticals